Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Shin H et al. – Three patients with recalcitrant PHN were treated with subcutaneous injection of recombinant human G–CSF 10 microg/kg once daily for 5 days. Assessments were performed at baseline and at weeks 1, 4, 8, 12 and 48 using the Brief Pain Inventory (BPI) and the Clinician Global Impression (CGI) score. All patients found improvement in BPI and CGI scores throughout the study. The authors suggest that G–CSF may help alleviate neuropathic pain and improve the overall quality of life in patients with PHN.


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address